Latest filing published 23 Jan 2026 for JB Chemicals & Pharmaceuticals Limited, €1.4M.
Filing timeline
BuySaleSandeep Nasa: trading record in brief
Sandeep Nasa is a declared insider of JB Chemicals & Pharmaceuticals Limited, with filings sourced from SEBI (PIT + SAST). Over a trading history stretching from 25 September 2024 to 23 January 2026, the count stands at 5 filings.
Sales make up the whole of the open-market record (2 sales, €998k). The rest of the record consists of 2 share grants.
The newest entry dates from 23 January 2026: a transaction of €1.4M, in JB Chemicals & Pharmaceuticals Limited. Filings reach the SEBI (PIT + SAST) feed a median of 2 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sandeep Nasa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 92,489 shares@ ₹1,600.0030.2% of flowEquity SharesSEBI:ff50e1181646b40cdc51ff000bbb62f4464f40d6
- 92,489 shares@ ₹1,884.6035.8% of flowEquity SharesSEBI:d566aad09340c0fc59f43445188f799fbf9c6541Canonical exit: 21 Apr 2026 (T+90)
- 31,161 shares@ ₹1,823.0012.1% of flowEquity SharesSEBI:21a135b6a7cf9e029fd097783273d70445798075Canonical exit: 12 Feb 2026 (T+90)
- 41,750 shares@ ₹1,815.101118.8% of flowEquity SharesSEBI:a9b741f6e19956cc67e3b105ba679752badca7eb
- 7,000 shares@ ₹1,903.11473.1% of flowEquity SharesSEBI:5e308f2dbed51a8fe8935bc3455e59eccd48d673
5 of 5 declarations